Literature DB >> 15782116

Multimodality expression profiling shows SEPT9 to be overexpressed in a wide range of human tumours.

Michael Scott1, Paula L Hyland, Gordon McGregor, Kenneth J Hillan, S E Hilary Russell, Peter A Hall.   

Abstract

Septins are an evolutionarily conserved family of GTPases with diverse functions including roles in cytokinesis that have been implicated in neoplasia. To address the potential role of SEPT9 in tumorigenesis, we assessed the expression of SEPT9 in 7287 fresh frozen human tissue samples and 292 human cell lines by microarray analysis. In addition, we used a sensitive RT-PCR strategy to define the expression of SEPT9 isoforms in archival formalin-fixed and paraffin-embedded normal human tissues. The mRNA data were further confirmed by immunohistological analyses of SEPT9 protein expression in normal human tissues using antisera that detect SEPT9 isoforms. Using these complementary approaches, we demonstrate that SEPT9 mRNA and protein are expressed ubiquitously, with the isoforms showing tissue-specific expression. The microarray analysis indicates that there is consistent overexpression of SEPT9 in diverse human tumours including breast, CNS, endometrium, kidney, liver, lung, lymphoid, oesophagus, ovary, pancreas, skin, soft tissue and thyroid. Since tumours are commonly associated with enhanced cell proliferation, we examined the possible correlation of Ki67 and SEPT9 expression in normal tissues and tumours. Our data indicate that the overexpression of SEPT9 in neoplasia is not simply a proliferation-associated phenomenon, despite its role in cytokinesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15782116     DOI: 10.1038/sj.onc.1208574

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  34 in total

1.  Expression of the SEPT9_i4 isoform confers resistance to microtubule-interacting drugs.

Authors:  Alex D Chacko; Simon S McDade; Severine Chanduloy; Stewart W Church; Richard Kennedy; John Price; Peter A Hall; S E Hilary Russell
Journal:  Cell Oncol (Dordr)       Date:  2012-01-26       Impact factor: 6.730

Review 2.  Understanding cytokinesis failure.

Authors:  Guillaume Normand; Randall W King
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 3.  Conquering the complex world of human septins: implications for health and disease.

Authors:  E A Peterson; E M Petty
Journal:  Clin Genet       Date:  2010-02-11       Impact factor: 4.438

4.  The expression patterns of Septin-9 after traumatic brain injury in rat brain.

Authors:  Hui Mao; Jiao Liu; Wei Shi; Qingfeng Huang; Xide Xu; Lanchun Ni; Feihui Zou; Jinlong Shi; Debao Li; Yonghua Liu; Jian Chen
Journal:  J Mol Neurosci       Date:  2013-05-23       Impact factor: 3.444

5.  Septin 9 promoter region methylation in free circulating DNA-potential role in noninvasive diagnosis of lung cancer: preliminary report.

Authors:  Tomasz Powrózek; Paweł Krawczyk; Tomasz Kucharczyk; Janusz Milanowski
Journal:  Med Oncol       Date:  2014-03-16       Impact factor: 3.064

6.  Quantitative proteomics reveals regulation of karyopherin subunit alpha-2 (KPNA2) and its potential novel cargo proteins in nonsmall cell lung cancer.

Authors:  Chun-I Wang; Kun-Yi Chien; Chih-Liang Wang; Hao-Ping Liu; Chia-Chen Cheng; Yu-Sun Chang; Jau-Song Yu; Chia-Jung Yu
Journal:  Mol Cell Proteomics       Date:  2012-07-25       Impact factor: 5.911

7.  Alternative splicing of sept9a and sept9b in zebrafish produces multiple mRNA transcripts expressed throughout development.

Authors:  Megan L Landsverk; Douglas C Weiser; Mark C Hannibal; David Kimelman
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

8.  Distinct roles of septins in cytokinesis: SEPT9 mediates midbody abscission.

Authors:  Mathew P Estey; Caterina Di Ciano-Oliveira; Carol D Froese; Margaret T Bejide; William S Trimble
Journal:  J Cell Biol       Date:  2010-11-08       Impact factor: 10.539

9.  AML1 amplification and 17q25 deletion in a case of childhood acute lymphoblastic leukemia.

Authors:  Tuna Gulten; Tahsin Yakut; Mutlu Karkucak; Birol Baytan; Adalet Meral Guneş
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

10.  SEPT9 gene sequencing analysis reveals recurrent mutations in hereditary neuralgic amyotrophy.

Authors:  M C Hannibal; E K Ruzzo; L R Miller; B Betz; J G Buchan; D M Knutzen; K Barnett; M L Landsverk; A Brice; E LeGuern; H M Bedford; B B Worrall; S Lovitt; S H Appel; E Andermann; T D Bird; P F Chance
Journal:  Neurology       Date:  2009-05-19       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.